SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-11-001995
Filing Date
2011-11-10
Accepted
2011-11-10 17:12:33
Documents
3
Period of Report
2011-11-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 VALEANT PHARMACEUTICALS INTERNATIONAL INC. FORM 8-K form8k.htm 8-K 30419
2 PRESS RELEASE ex99_1.htm EX-99.1 12617
3 logo2.jpg GRAPHIC 7760
  Complete submission text file 0001341004-11-001995.txt   55293
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 111196313
SIC: 2834 Pharmaceutical Preparations